Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine dose comparison with ropivacaine for cesarean spinal anesthesia
IRCT20141209020258N72Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and ropivacaine in caesarean delivery (C-section) (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Change in hemodynamic parameters, Block quality and 1 more. Started Nov 2017; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on IRCT20141209020258N72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N72.